Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) Total debt
Integer Holdings Corporation's total debt at the end of fiscal 2025 was $1.2B, up 19.7% from $1.0B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.3B. Over the past ten years it has ranged from $731.3M (fiscal 2020) to $1.7B (fiscal 2016); the current reading is higher than 73% of that period. Integer Holdings Corporation ranks 14th of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.2B | 19.71% |
| FY2024 | $1.0B | 4.51% |
| FY2023 | $970.2M | 3.96% |
| FY2022 | $933.3M | 11.69% |
| FY2021 | $835.6M | 14.27% |
| FY2020 | $731.3M | (10.25%) |
| FY2019 | $814.8M | (11.96%) |
| FY2018 | $925.5M | (42.49%) |
| FY2017 | $1.6B | (6.99%) |
| FY2016 | $1.7B | 0.94% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.3B | (1.58%) |
| Jun 2026 | $1.3B | (1.14%) |
| Mar 2026 | $1.3B | 7.44% |
| Dec 2025 | $1.2B | (0.46%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| ITGR Integer Holdings Corporation | $1.3B |
| HAE Haemonetics Corporation compare | $1.1B |
| NEOG Neogen Corporation compare | $774.2M |
| IRTC iRhythm Holdings, Inc. compare | $651.9M |
| LIVN LivaNova PLC compare | $299.1M |
| TXG 10x Genomics compare | $98.0M |
| UFPT UFP Technologies, Inc. compare | $96.0M |
| TMDX TransMedics Group, Inc. compare | $54.8M |
| AXGN AxoGen, Inc. compare | $17.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement